Frank T. Watkins, Director at Shockwave Medical, Inc. (SWAV), sold 2,000 shares at $197.94 ($398K) on 2024-01-08, disclosed to the SEC on 2024-01-10.
Scheduled sale ($398k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $196.15 | 200 | $39K | 9.9% |
| 2 | $197.94 | 700 | $139K | 34.8% |
| 3 | $200.17 | 1,100 | $220K | 55.3% |
| Total | $198.99 avg | 2,000 | $398K | 100% |
| Filing → |
| SWAV | SELL | 2023-11-21 | $926K | — | Filing → |
| SWAV | SELL | 2023-10-23 | $608K | — | Filing → |
| SWAV | SELL | 2023-09-21 | $628K | — | Filing → |